Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference

STAMFORD, Conn., Nov. 13  /PRNewswire-FirstCall/ -- Speedus Corp. (NASDAQ: SPDE) today announced that it will be releasing a free trial version of its Zargis Cardioscan software during the American Heart Association's 2009 Scientific Sessions conference, taking place this November 15-17 in Orlando. Zargis is exhibiting at the conference with 3M Littmann, the developers of the companion hardware -- the 3M Littmann Electronic Stethoscope Model 3200 -- which wirelessly transfers heart, lung and other body sounds to Zargis Cardioscan and Zargis StethAssist software for further analysis.

Cardioscan represents a true breakthrough in stethoscope use and was recently named 2009 product of the year by Popular Science magazine. This free trial version was created to allow healthcare professionals to experience the benefits of Cardioscan's diagnostic support features as well as Zargis' accompanying tele-auscultation system.

The annual American Heart Association's Scientific Sessions conference is the world's pre-eminent gathering of healthcare professionals devoted to understanding, treating, assessing, and preventing cardiovascular disease and stroke. The 2008 Scientific Sessions event was attended by more than 17,000 medical professionals.

About Zargis Medical Corp.

Zargis Medical Corp. develops advanced diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists and other healthcare professionals. Zargis was formed in 2001 when Siemens Corporate Research, a division of Siemens AG (NYSE:SI), and Speedus Corp. co-invested to develop and market an advanced acoustic technology designed to detect heart abnormalities identified through analysis of heart sounds.

About Zargis Cardioscan

Zargis Cardioscan is the first and only computer-assisted medical device designed to support physicians in analyzing heart sounds for the identification of suspected systolic and diastolic murmurs. Cardioscan is a non-invasive device that is easy to use, portable, and takes just minutes to perform. The device implements voice-guided protocol and a graphical user interface while maintaining an efficient physician workflow. Cardioscan provides a summary of findings in terms that are readily understood by physicians and offers an additional range of quantitative auscultatory information that cannot be obtained through listening alone. Cardioscan is intended to enhance auscultation a procedure that has been universally employed through a stethoscope for nearly two-hundred years.

For additional information about Zargis or Speedus Corp., contact Peter Hodge at 888.773.3669 (ext. 23) or  or visit the following Web sites: http://www.zargis.com/ and http://www.speedus.com/.

Statements contained herein that are not historical facts, including but not limited to statements about the Company's product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, the continuing development of the Company's sales, marketing and support efforts.

  Contact: Peter Hodge
  Tel: [phone] (ext. 23)
  Email: 

DATASOURCE: Speedus Corp.



CONTACT:  Peter Hodge, 1-888-773-3669 (ext. 23), 



Web Site:  http://www.speedus.com/ 

Copyright